Extended guide RNA with CRISPR effectors and reverse transcriptase broadens plant allele editing beyond base editor PAM and residue limits.
A Type V CRISPR-Cas, reverse transcriptase, and extended guide RNA expand allele editing beyond conventional base changes in plants.
Guide RNA-mediated CRISPR effectors improve sequence-specific RNA targeting while limiting off-target effects for editing, knockdown, and diagnostics.
Error-prone reverse transcription mutates a variable region to generate diversified molecular libraries with high efficiency for binding partner screening.
Linked Cas and epigenetic regulator domains enable precise target binding with sustained gene expression changes lasting over 30 days.
Mutant Cas-CLOVER, guide RNA, and lipid nanoparticles improve targeted genome integration yield while reducing unintended edits for cell therapy.
RNA-editing chimeric proteins label target mRNA for sequencing-based translation rate measurement without ribosomal RNA removal.
Segmented trans-splicing molecules overcome AAV size limits to repair ABCA4 and CEP290 mutations linked to Stargardt disease and LCA10.
RNA barcodes and fusion-protein trafficking link synaptic connectivity with single-cell transcriptomics for scalable, minimally invasive neuroanatomy mapping.
RNase III cleavage of stem-loop transcripts enables single-delivery expression of multiple guide polynucleotides for plant genome editing.
Ligand-induced dimerization recruits ADAR to output RNA, enabling post-transcriptional control of polypeptide expression with targeted specificity.
Targeted RID mutations improve VP1 soluble expression and folding in E. coli, enabling faster, more uniform multigenotype norovirus VLP production.
Tethering proteins and engineered small nuclear RNAs promote exon insertion into target RNA, improving genetic defect correction without CRISPR.